INTRODUCTION

S
ince laparoscopic cholecistectomy became the golden standard in treatment of cholelithiasis, minimally invasive surgery has become ever popular in treatment of not only benign, but also some malignant diseases. The advantage of minimally invasive surgery is not related only to avoidance of big surgical incision, but also to a significant decrease of operative trauma and consecutive inflammatory response and pain, which positively affects the reduction of postoperative complications, de-crease hospital stay and increase quicker return to normal activities and patient satisfaction.
Unlike benign pathology, progress of laparoscopy in cancer surgery has been slow because of the fear for safety and oncological adequacyin comparison to already proven open procedures 1 . However, the initial fear has been replaced by optimism as the results from a numerous studies have shown equivalent, if not superior, results to open surgery.
When malignant pathology of gastric cancer is in question, minimally invasive procedures were initially introduced as a diagnostic toolin staging of the disease. Staging laparoscopyincreased accuracyof other diagnostic procedures, primarily of computerized tomography in the detection of peritoneal seeding.
As surgical experience increased, diagnostic procedures were replaced by therapeutic procedures. The first series of Billroth I operations was published by Kitano et al. in 1994 2 . Initial experience opened the door to introducing other, more complex, minimally invasive surgical procedures in treatment, at first for benign and afterwards malignant gastric diseases 3, 4 . Watson et al. published series of Billroth II operations in 1995, Choi et al. a laparoscopically assisted subtotal gastrectomy the next year, and Uyamaet al. a laproscopic D2 gastrectomy in 1999 5, 6, 7 .In the period from 1991-2003, 7800 minimally invasive surgical procedures for patients suffering from gastric cancer, were performed in Japan 8 . However, the initial experience in the resection of gastric cancers was not based on extensive, but rather limited resections of early, mucosal cancers. That mostly referred to laparoscopic wedge resections -LWR and intragastric mucosal resections -IGMR. It was due to a fact that mucosal cancers, most often, represent localized diseases. According to data from the Japanese and the International Society for Gastric Cancer, predominance of lymphonodal metastases in perigastric lymph nodesfor mucosal cancers (m) is between 1.9% and 4.0%. When cancer invadethe basal membrane and enters the submucosallayer (sm), the situation is dramatically changed, so that metastases in regional lymphatic nodes can be anticipated with over 20% of patients 9 . Furthermore, based on macroscopic characteristics of lymphatic nodes, preoperative and intraoperative assessment of dispersion is not feasible 10 As prevalence of gastric cancer in general, especially early cancers is highest in Japan, the most important study of importance of minimally invasive limited resectionwas conducted in Japan. In the period from 1992 to 2001, Japanese Association for Endoscopic Surgery conducted a study that included over 1400 patients with mucosal cancer, with the goal of assessment of significance of LWR and IGMR in the treatment of small mucosal gastric cancers 12 . LWR was conducted with 1428 patients and IGMR with 26. The criteria for exclusion from the study were: submucosal invasion or invasion of lymphatic or blood vesselsconfirmed by endoscopic biopsy, cancer diameter >3 cm, non-differentiated hystological type and presence of ulceration. Notwithstanding strict clinical and hystological criteria, with as much as 20% of patients conversion to open gastrectomy had to be made after LWR or IGMR. The criteria for the conversion to open radical procedure were: hystologically positive resection line, subsequent hystologically proven invasion of vein or lymphatic vessels in the gastric wall and invasion of middle or deep submucosal layer of gastric wall.
Due to high ratio of conversion and advancement in endoscopic and minimally invasive surgical techniques (laparoscopic resection of stomach and lymphonodal dissection), LWR and IGMR conceded their place to less invasive or more extensive minimally invasive resection procedures.
Shortly after obtaining initial experience with LWR and IGMR, another assessment of significance of minimally invasive (laparoscopic) gastrectomy in the treatment of early gastric cancer study was initiated in Japan 2 . Under auspices of Japanese Research Society for Gastric Cancer and Japanese Association for Endoscopic Surgery, a study group was formed, that designed a multicentric study in which 16 surgical institutions and 1294 patiens were involved. The conclusion of this vast study was that laparoscopic gastrectomy is a safe procedure in treatment of early gastric cancer and that oncological outcome is the same as after open surgery.
When the western population is concerned, the first experiences in stomach resection were acquired in the surgical treatment of morbid obesity (Roux-en-Y bypass) 4, 13 . It enabled an enviable experience in resection technique, but not in lymphonodal dissection. Alongside the advancement of surgical experience, both in the West and in the Far East, minimally invasive resection procedures were also expanded to invasive gastric cancer.
In contemporary literature different minimally invasive procedures in treatment of gastric cancer can be found: total laparoscopic gastrectomy, laparoscopically assisted gastrectomy and hand assisted laparoscopic gastrectomy. In addition, the surgical procedures vary widely in respect to extent of resection and especially lymph nodal dissection.
Through insight to available medical literature we found two meta-analysis that evaluate the laparoscopicdistal gastrectomy in gastric cancer treatment. One was performed by Hobsonet al.from Osaka (Japan) and published it in World Journal of Surgery in 2006, and the other by Mohamed Memo et al., from Queensland (Australia) and published it in Surgical Endoscopy in 2008. 14, 15 What is the conclusion of these studies? The duration of laparoscopic distal gastrectomy (LADG) is significantly greater than open gastrectomy (OG). It has considerable implications to patients as well as medical services. Increased duration of surgery and exposure to prolonged anesthesia increases morbidity and probably mortality in category of older patients with substantial associated comorbidity. Increase duration of surgery and anesthesia significantly increases both direct costs of surgical procedure and overall treatment costs.
The duration of LADG is probably in direct correlation with phase of learning curve, since LADG is a relatively new procedure. With growth of experience in LADG reduction of surgery duration is to be expected.
When intraoperative blood loss is analyzed, the greatest number of studies agrees that LADG is associated with less blood loss in comparison to OG 3 . Negative effect of blood transfusion on survivalafter surgical resection for cancer is well known, however the mechanism of immunomodulatory effect is still not totally explained.
Oncological adequacy of resection procedure is based on possibility to ensure cancer free resection margins and adequate lymphonodal dissection 16 . Assessment of safe resection line during LADG is being assessed the same way as during OG. In addition, it is a generally accepted that standard D2 dissection is possible to perform laparoscopically 17, 18 . A particular problem that initially was attached to laparoscopy are "port-site" metastasis. Up to the introduction of protective sack, extraction of tumor through relatively narrow opening in abdominal wall in stigated embedding of cancer cells into the abdominal wall and a higher percent of local disease relapse. Nowadays, the protective sac is standardly used during the extraction of the tumor from the abdominal cavity.Today, it is known that prevalence of "port site" metastases is 0,79% 1 . Since relapse of the disease on surgical incision prevalence is 0,86% with OG, "port site" metastases are no longer being disputed as a significant problem.
Except for Kitano et al. study, majority of others consider that in group of patients that under-went LADG, restoration of intestine peristalsis (flatus passage) is earlier and it is possible to start with peroral nutrition sooner 2, 19, 20 . Earlier peroral nutrition is in direct link with possibility of earlier discharge from hospital and that directly affects the overall economical effect of treatment.
Three out of four controlled studies included in the meta-analysis determined a trend of earlier hospital discharge with patients that underwent a minimally invasive surgery 10 . There are no publications so far that analyze importance of minimally invasive approach in earlier return to normal life activities with patients that underwent surgery for gastric cancer. However, general conclusion is that frequency, dose and duration of analgesia after LADG is significantly lower in comparison to the OG. The reason for it is probably the absence of large abdominal incision in the patients who were operated with minimally invasive approach. 10 . Lower occurrence of overall complications is addressed tofewer emergence of problems related to operative incision, respiratory complications and ischemic heart disease. Technical problems attached to laparoscopic creation of esophagojejunal anastomosis, were overcome with time. 21 Since the inflammatory response after LADG is significantly lower than after OG, the adhesion rate is also lower. It causes rarer occurrence of late postoperative ileus in a group of surgically treated with minimally invasive techniques, however the difference in relation to OG is statistically not significant since in overall, late postoperative ileus after the surgery of malignant gastric disease is a relatively rare phenomena 9 . Lastly, there is no significant difference in mortality after the laparoscopic and open distal gastrectomy 10 .
CONCLUSION
Laparoscopic gastrectomy is a safe and oncologically adequate, but technically demanding and time consuming procedure. It is reserved for surgeons with experience in open surgery of malignant gastric diseases and surgeons with major experience in advanced laparoscopic procedures. Even then, the learning curve is long. Despite all that, the ever greater number of surgeons around the world accepts the minimally invasive approach in treatment of this disease.
Most comparative studies relate to early gastric cancers and cancers of distal part of stomach. The importance of laparoscopic gasterctomy in the treatment of invasive gastric cancer is still undefined and therefore, remains a topic full of controversies. Because of this, comprehensive multicentric randomized controltrials are needed. Another open question is the one of cost-effectiveness of laparoscopic and open gastrectomy and it requires thorough evaluation.
SUMMARY MINIMALNO INVAZIVNA HIRURGIJA KARCINOMA @ELUCA
Za razliku od benigne patologije, napredak minimalno invazivne hirurgije u le~enju malignih tumora bio je usporen zbog straha od bezbednosti i onkološke opravdanosti minimalno invazivnih tehnika u poredenju sa ve} dokazanim otvorenim procedurama. Medjutim, inicijalni strah zamenio je optimizam zasnovan na brojnim studijama koje su dokazale jednake, ako ne i superiorne rezultate u odnosu na otvorene procedure. Laparoskopska gastrektomija je sigurna i onkološki adekvatna ali tehni~ki i vremenski zahtevna procedura. Ve}ina komparativnih studija odnosi se na rane karcinome 'eluca i karcinome distalnog dela 'eluca. Zna~aj laparoskopske gastrektomije u le~enju invazivnog carcinoma 'eluca još nije definisan i stoga i dalje ostaje tema puna kontroverzi. Još jedno otvoreno pitanje je odnos troškova i efekata laparoskopske i otvorene gastrektomije i ono zahteva kompletnu evalu-aciju.
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